טוען...
Mechanisms of Resistance to KRAS(G12C) Inhibitors
SIMPLE SUMMARY: KRAS is a gene that is commonly mutated in cancer, especially in pancreatic, lung and colorectal cancers. Despite its importance, scientists have for many years been unable to create a drug that can inhibit function of the KRAS protein. Recently, several drugs have been created that...
שמור ב:
| הוצא לאור ב: | Cancers (Basel) |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7795113/ https://ncbi.nlm.nih.gov/pubmed/33466360 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13010151 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|